Buy, Sell or Hold: Intuitive Surgical Inc. (ISRG-Q) — Stock Predictions at Stockchase

skip to content

Home Daily Stock Opinions and Ratings Intuitive Surgical Inc. (ISRG-Q)

NASDAQ:ISRG

245.04

4.23 (1.76%) 1d

BUY on WEAKNESS

Soared during lockdowns, but got obliterated when the Fed declared war on inflation and names like this got hit. It lost more than half its value and has rebounded partly. Early this year, they pre-announced disappointing number though the company is still growing. Has a good track record over the past 10 years.

biotechnology / pharmaceutical

HOLD

ISRG vs. SYK Reported last night, market not too happy, but this is short term. At 50x PE, expensive on any traditional valuation. Has no real competition in robotic surgery market. Great franchise and platform. Will grow earnings over next decade 200-300%. Because SYK is in hips and knees, it's not in direct competition. SYK's space is more competitive, but also has much lower valuation. With Covid shortages ending, SYK could see some upside next 3-4 months.

biotechnology / pharmaceutical

DON'T BUY

He's looked at it for 20 years. Their technological, Da Vinci, is a successful robotic surgical tool. But their PE is very high; people pay up for this technology, which has gone up and down (down during Covid when there were few surgeries). But shares have bounced back. PE remains too high. Pass.

biotechnology / pharmaceutical

WATCH

They make surgical robots. Their install base is growing, but their PE always been too high. They might change because shares have come off. Don't buy, but watch.

biotechnology / pharmaceutical

HOLD

He likes it and will stick by it, but the market isn't fond of this sector.

biotechnology / pharmaceutical

TOP PICK

Leader in robotic surgery. Relatively early days in this space, and ISRG has a massive head start. Both JNJ and MDT are trying to enter this market and having trouble. Recurring revenue model drives financial performance. Less invasive, new product for diagnosing lung tumours. Expensive PE, but highly profitable. He expects 10-15% growth of topline revenue for next decade. No dividend. (Analysts’ price target is $250.34)

biotechnology / pharmaceutical

PARTIAL BUY

Leader in robotic surgeries. More volatility due to concentration in that area. Still trades at 36x earnings. Solid growth franchise. Could be subject to M&A. He prefers a more diversified company. You could ladder into it.

biotechnology / pharmaceutical

BUY

Add to position? Yes, as Covid peaks, this stock will go back up though not much beyond its highs. This was hurt by lockdowns which halted surgeries.

biotechnology / pharmaceutical

STRONG BUY

Very well positioned in robotics surgery, the leader by far. Go-to name. More and more procedures will be performed by robots. Very bullish.

biotechnology / pharmaceutical

BUY

Great management and growth. He's a big fan.

biotechnology / pharmaceutical

PAST TOP PICK

(A Top Pick Aug 24/20, Up 18%) Leader in robotic surgery. Penetration is only about 5% right now, so lots of room to grow. Expensive, but very sure growth. Can hold it forever.

biotechnology / pharmaceutical

PAST TOP PICK

(A Top Pick Apr 17/20, Up 65%) Doctors are trained to use their system so competitors find it hard to get into the market. They are starting to reduce prices on some of their tools ahead of the coming competition. He will hold it for the foreseeable future.

biotechnology / pharmaceutical

BUY

Allan Tong’s Discover Picks I recommended this last August. As we face the reopening and eventual recovery, elective surgeries will bounce back and there will be a huge backlog to process. This backlog spells a boom for any company directly tied to surgeries. That’s short term. A longer-term tailwind for ISRG stock is the continued adoption of robotic surgery and this is where the automation stock shines bright. Robotic surgeries increased from 1.8% of all operations in 2012 to 15.1% in 2018. Read 3 Underestimated Automation Stocks for our full analysis.

biotechnology / pharmaceutical

PAST TOP PICK

(A Top Pick Jan 02/20, Up 27%) A great long-term play on robotically assisted surgery, a leader in this area. It's an expensive growth stock, but the outlook is so strong it's worth it. There's lots of room globally for surgery to adopt this technology.

biotechnology / pharmaceutical

BUY

Fractional shares to buy instead of playing the short squeeze of GameStop, AMC, etc. They make precision surgical machines which amazes him. Promising.

biotechnology / pharmaceutical

Showing 1 to 15 of 29 entries

«
‹
1
2
›
»

Next Page

Intuitive Surgical Inc.(ISRG-Q) Rating

Ranking : 4 out of 5

Bullish - Buy Signals / Votes : 2

Neutral - Hold Signals / Votes : 2

Bearish - Sell Signals / Votes : 1

Total Signals / Votes : 5

Stockchase rating for Intuitive Surgical Inc. is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Intuitive Surgical Inc.(ISRG-Q) Frequently Asked Questions

What is Intuitive Surgical Inc. stock symbol?

Intuitive Surgical Inc. is a American stock, trading under the symbol ISRG-Q on the NASDAQ (ISRG). It is usually referred to as NASDAQ:ISRG or ISRG-Q

Is Intuitive Surgical Inc. a buy or a sell?

In the last year, 5 stock analysts published opinions about ISRG-Q. 2 analysts recommended to BUY the stock. 1 analyst recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Intuitive Surgical Inc..

Is Intuitive Surgical Inc. a good investment or a top pick?

Intuitive Surgical Inc. was recommended as a Top Pick by on . Read the latest stock experts ratings for Intuitive Surgical Inc..

Why is Intuitive Surgical Inc. stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Intuitive Surgical Inc. worth watching?

5 stock analysts on Stockchase covered Intuitive Surgical Inc. In the last year. It is a trending stock that is worth watching.

What is Intuitive Surgical Inc. stock price?

On 2023-03-23, Intuitive Surgical Inc. (ISRG-Q) stock closed at a price of $245.04.

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : hello@stockchase.com.

© Stockchase Inc.